Ensoma inks $70m Series A

Ensoma, a genomic medicine company, has raised $70 million in Series A financing.

Ensoma, a genomic medicine company, has raised $70 million in Series A financing. The lead investor was 5AM Ventures. Other investors that participated in the round were F-Prime Capital, Takeda Ventures, Viking Global Investors, Cormorant Asset Management, RIT Capital Partners and Alexandria Venture Investments.

Source: Press Release